These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 9308731)

  • 1. Hepatocyte growth factor and c-MET in benign and malignant peripheral nerve sheath tumors.
    Rao UN; Sonmez-Alpan E; Michalopoulos GK
    Hum Pathol; 1997 Sep; 28(9):1066-70. PubMed ID: 9308731
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Malignant peripheral nerve sheath tumour arising within neurofibroma. An immunohistochemical analysis in the comparison between benign and malignant components.
    Watanabe T; Oda Y; Tamiya S; Masuda K; Tsuneyoshi M
    J Clin Pathol; 2001 Aug; 54(8):631-6. PubMed ID: 11477120
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CD44-independent hepatocyte growth factor/c-Met autocrine loop promotes malignant peripheral nerve sheath tumor cell invasion in vitro.
    Su W; Gutmann DH; Perry A; Abounader R; Laterra J; Sherman LS
    Glia; 2004 Feb; 45(3):297-306. PubMed ID: 14730703
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ERBB2 and ERBB3 Growth Factor Receptors, Neuregulin-1, CD44 and Ki-67 Proliferation Index in Neurofibromatosis Type 1-associated Peripheral Nerve Sheath Tumors.
    Friedrich RE; Nörnberg LKN; Hagel C
    Anticancer Res; 2022 May; 42(5):2327-2340. PubMed ID: 35489721
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activation of Receptor Tyrosine Kinases Mediates Acquired Resistance to MEK Inhibition in Malignant Peripheral Nerve Sheath Tumors.
    Wang J; Pollard K; Calizo A; Pratilas CA
    Cancer Res; 2021 Feb; 81(3):747-762. PubMed ID: 33203698
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vascular endothelial growth factor, basic fibroblast growth factor and epithelial growth factor receptor in peripheral nerve sheath tumors of neurofibromatosis type 1.
    Friedrich RE; Beer C; Glatzel M; Hagel C
    Anticancer Res; 2015 Jan; 35(1):137-44. PubMed ID: 25550544
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Coexpression of hepatocyte growth factor and receptor (Met) in human breast carcinoma.
    Tuck AB; Park M; Sterns EE; Boag A; Elliott BE
    Am J Pathol; 1996 Jan; 148(1):225-32. PubMed ID: 8546209
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genomic Status of
    Peacock JD; Pridgeon MG; Tovar EA; Essenburg CJ; Bowman M; Madaj Z; Koeman J; Boguslawski EA; Grit J; Dodd RD; Khachaturov V; Cardona DM; Chen M; Kirsch DG; Maina F; Dono R; Winn ME; Graveel CR; Steensma MR
    Cancer Res; 2018 Jul; 78(13):3672-3687. PubMed ID: 29720369
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of Met/hepatocyte growth factor receptor gene and malignant behavior of musculoskeletal tumors.
    Scotlandi K; Baldini N; Oliviero M; Di Renzo MF; Martano M; Serra M; Manara MC; Comoglio PM; Ferracini R
    Am J Pathol; 1996 Oct; 149(4):1209-19. PubMed ID: 8863670
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatocyte growth factor is a mitogen for Schwann cells and is present in neurofibromas.
    Krasnoselsky A; Massay MJ; DeFrances MC; Michalopoulos G; Zarnegar R; Ratner N
    J Neurosci; 1994 Dec; 14(12):7284-90. PubMed ID: 7996175
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Methylation-based classification of benign and malignant peripheral nerve sheath tumors.
    Röhrich M; Koelsche C; Schrimpf D; Capper D; Sahm F; Kratz A; Reuss J; Hovestadt V; Jones DT; Bewerunge-Hudler M; Becker A; Weis J; Mawrin C; Mittelbronn M; Perry A; Mautner VF; Mechtersheimer G; Hartmann C; Okuducu AF; Arp M; Seiz-Rosenhagen M; Hänggi D; Heim S; Paulus W; Schittenhelm J; Ahmadi R; Herold-Mende C; Unterberg A; Pfister SM; von Deimling A; Reuss DE
    Acta Neuropathol; 2016 Jun; 131(6):877-87. PubMed ID: 26857854
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of insulin-like growth-factor-1 receptor (IGF-1R) in peripheral nerve sheath tumors in neurofibromatosis type 1.
    Friedrich RE; Keiner D; Hagel C
    Anticancer Res; 2007; 27(4A):2085-90. PubMed ID: 17649826
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Malignant Peripheral Nerve Sheath Tumor.
    James AW; Shurell E; Singh A; Dry SM; Eilber FC
    Surg Oncol Clin N Am; 2016 Oct; 25(4):789-802. PubMed ID: 27591499
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential expression of angiogenic factors in peripheral nerve sheath tumors.
    Wasa J; Nishida Y; Suzuki Y; Tsukushi S; Shido Y; Hosono K; Shimoyama Y; Nakamura S; Ishiguro N
    Clin Exp Metastasis; 2008; 25(7):819-25. PubMed ID: 18679811
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Overexpression of the hepatocyte growth factor (HGF) receptor (Met) and presence of a truncated and activated intracellular HGF receptor fragment in locally aggressive/malignant human musculoskeletal tumors.
    Wallenius V; Hisaoka M; Helou K; Levan G; Mandahl N; Meis-Kindblom JM; Kindblom LG; Jansson JO
    Am J Pathol; 2000 Mar; 156(3):821-9. PubMed ID: 10702398
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human peripheral nerve sheath neoplasm: expression of Schwann cell-related markers and their relation to malignant transformation.
    Yasuda T; Sobue G; Ito T; Doyu M; Sugiura I; Hashizume Y; Kato K
    Muscle Nerve; 1991 Sep; 14(9):812-9. PubMed ID: 1656253
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatocyte growth factor and c-Met/hepatocyte growth factor receptor in pulmonary adenocarcinomas: an evaluation of their expression as prognostic markers.
    Takanami I; Tanana F; Hashizume T; Kikuchi K; Yamamoto Y; Yamamoto T; Kodaira S
    Oncology; 1996; 53(5):392-7. PubMed ID: 8784474
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of hepatocyte growth factor/scatter factor and its receptor c-Met in brain tumors: evidence for a role in progression of astrocytic tumors (Review).
    Moriyama T; Kataoka H; Koono M; Wakisaka S
    Int J Mol Med; 1999 May; 3(5):531-6. PubMed ID: 10202187
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of Ras signaling pathway proteins and developmental factors in peripheral nerve sheath tumors of patients with neurofibromatosis type 1.
    Hagel C; Nörnberg LKN; Friedrich RE
    Clin Neuropathol; 2023; 42(4):150-160. PubMed ID: 37226590
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Atypical neurofibromas in neurofibromatosis type 1 are premalignant tumors.
    Beert E; Brems H; Daniëls B; De Wever I; Van Calenbergh F; Schoenaers J; Debiec-Rychter M; Gevaert O; De Raedt T; Van Den Bruel A; de Ravel T; Cichowski K; Kluwe L; Mautner V; Sciot R; Legius E
    Genes Chromosomes Cancer; 2011 Dec; 50(12):1021-32. PubMed ID: 21987445
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.